International Business Machines Corporation

New York Stock Exchange
Back to all articles
Slightly Bullish +25

Stifel Resets IBM Stock Price Target Ahead of Earnings - Yahoo Finance

📉 Stifel reduced its IBM stock price target from $340 to $290 while maintaining a Buy rating due to geopolitical headwinds and currency moves.

🌪️ Analysts cited the Gulf conflict as a potential negative impact on software and services growth in the first quarter.

💰 The closing of the Confluent acquisition ahead of schedule was highlighted as a positive factor supporting IBM's revenue.

📈 Stifel projected 2026 constant currency revenue growth between 4.5% and 5%, slightly below company guidance.

🔢 Earnings per share were estimated at $12.38, representing approximately 7% year-over-year growth according to the analyst firm.

⏱️ IBM is scheduled to report first-quarter earnings results on April 22, which analysts expect will be seasonally weak.

📉 BMO Capital Markets lowered its price target to $270 with a Market Perform rating after Q1 software organic growth missed expectations.

🤖 Wedbush Securities analyst Daniel Ives cut the price target to $320 citing $600M of Confluent dilution and near-term consulting softness.

🏛️ Bank of America reiterated a Buy rating with a $300 price objective following IBM's Q1 revenue and earnings beats.

💼 The first-quarter beat was primarily driven by strength in the infrastructure segment and lower-than-expected operating expenses.

📝 Management reaffirmed its fiscal 2026 outlook, expecting over 5% constant-currency revenue growth and $1 billion in free cash flow.

⚙️ IBM raised software guidance to above 10% constant-currency growth, influenced by Confluent's early contributions and strong data product performance.

📉 Organic software growth decelerated quarter-over-quarter, particularly in automation and transaction processing areas.

📊 The consulting segment faced margin compression of 43 basis points year-on-year, drawing attention regarding AI-driven service demand disruption.

🏗️ Infrastructure performance remained positive with mainframe activity helping offset broader cyclical headwinds.

💸 Analysts noted ongoing cost savings initiatives tracking toward a multi-billion-dollar run rate to support cash generation.

🔮 Bank of America views IBM's shift toward higher-margin software and stable free cash flow as key longer-term supports.

⚡ Emerging technologies such as quantum computing are seen as potential optional upside factors by Bank of America analysts.

📉 Shares traded down 8% at approximately $232 despite the positive guidance revisions on revenue and earnings per share.

⚠️ Investors remain cautious regarding slowing organic software growth and limited upward revision to full-year guidance.

⚖️ Bank of America concluded that IBM's balanced positioning allows cost discipline to offset near-term market volatility.

Bullish Signals
  • Bank of America maintained its 'Buy' rating on IBM with a price objective of $300, valuing the stock at 20 times projected 2027 free cash flow.
  • IBM reported first quarter revenue and earnings per share ahead of consensus expectations, supported primarily by strength in its infrastructure segment and lower-than-expected operating expenses.
  • Management reaffirmed its full-year fiscal 2026 outlook, including expectations for more than 5% constant-currency revenue growth and $1 billion in free cash flow.
  • IBM's software segment guidance was modestly raised to above 10% constant-currency growth, reflecting early contributions from the Confluent acquisition and stronger-than-expected performance in data products.
  • Analysts highlighted ongoing productivity initiatives and cost savings targets tracking toward a multi-billion-dollar run rate to support margins.
  • International Business Machines Corporation is included among the 10 Best May Dividend Stocks to Buy for investors seeking income.
  • The closing of the Confluent acquisition ahead of schedule was noted as a tailwind supporting future revenue growth.
  • Bank of America analysts highlighted the mix shift toward higher-margin software, stable free cash flow generation, and optional upside from emerging technologies such as quantum computing as key longer-term supports.
Risk Factors
  • Stifel lowered its price target on IBM from $340 to $290 ahead of earnings, signaling analyst concern about valuations despite a Buy rating.
  • BMO Capital Markets reduced IBM's price recommendation to $270 and maintained a Market Perform rating due to disappointing Q1 software organic growth.
  • Wedbush Securities analyst Daniel Ives cut the price target on IBM from $340 to $320, citing near-term softness in consulting and concerns over $600M Confluent dilution.
  • Stifel cited potential headwinds from the Gulf conflict affecting software and services growth alongside a meaningful foreign exchange move that could impact earnings.
  • Bank of America noted mixed signals within software and consulting performance despite a revenue and earnings beat, characterizing the market reaction as tempered.
  • The bank highlighted that organic software growth slowed quarter-on-quarter, with specific deceleration visible in automation and transaction processing areas.
  • IBM's consulting segment faced margin compression of 43 basis points year-on-year, raising concerns about profitability trends amid AI-driven disruption to services demand.
  • Despite reporting revenue and earnings ahead of consensus, the market reaction was muted due to slowing momentum and uncertainty around full-year guidance adjustments.
  • Stifel revised its 2026 constant currency revenue estimate to growth of 4.5% to 5%, which sits below the company's own guidance of 5%.
Full Analysis
Stifel Analytics has adjusted its price target on International Business Machines (NYSE:IBM) down to $290 from $340 while maintaining a Buy rating. The firm cited potential headwinds from the Gulf conflict impacting software and services growth, as well as meaningful foreign exchange moves, offset by the tailwind from the Confluent acquisition closing ahead of schedule. Stifel revised its 2026 constant currency revenue estimate to 4.5% to 5% growth, slightly below consensus and company guidance, with modeled earnings per share expected at $12.38, representing about 7% growth. The firm anticipates an in-line quarter for IBM, which is scheduled to report first-quarter earnings on April 22, noting the period is seasonally weak within an uncertain macroeconomic environment. Other analysts have also adjusted their outlooks around the same time. On April 23, BMO Capital Markets lowered its price recommendation to $270 from $290 and reiterated a Market Perform rating due to below-expected Q1 software organic growth despite stronger Red Hat performance. Similarly, Wedbush Securities analyst Daniel Ives reduced his price target for IBM to $320 from $340, citing lower multiples related to $600 million of Confluent dilution and near-term consulting softness, though Wedbush maintained its FY26 revenue and free cash flow outlook while noting beats in Q1 results. These actions occurred against a backdrop where IBM shares traded down approximately 8% to around $232 prior to recent earnings discussions. Bank of America analysts have reiterated their constructive view with a Buy rating and a price objective of $300, valuing IBM based on 20 times projected 2027 free cash flow. While IBM reported first-quarter revenue and earnings ahead of consensus expectations driven by infrastructure segment strength and lower operating expenses, the bank characterized the reaction as tempered due to mixed signals in software and consulting performance. Bank of America highlighted that while guidance for the software segment was modestly raised to above 10% constant currency growth reflecting Confluent contributions, organic software growth slowed quarter-on-quarter with deceleration in automation and transaction processing areas. Additionally, consulting margins compressed by 43 basis points year-on-year, raising ongoing scrutiny regarding profitability trends amidst concerns about AI-driven disruption to services demand. Despite these near-term concerns, the bank maintained its FY26 outlook for over 5% constant currency revenue growth and $1 billion in free cash flow, emphasizing IBM's balanced positioning supported by cost discipline, cash generation, and strategic shifts toward higher-margin software and emerging technologies like quantum computing.